Print this page

You are here

Freedom of information disclosure log

This page contains publicly available information released following a freedom of information (FOI) access request.

About the disclosure log

The APVMA is required by section 11C of the?Freedom of Information Act 1982?(the FOI Act) to publish a freedom of information disclosure log on its website. The disclosure log lists information that has been released in response to FOI access requests. This requirement has applied since 1 May 2011.

The disclosure log requirement does not apply to:

  • personal information about any person if publication of that information would be ‘unreasonable’
  • information about the business, commercial, financial or professional affairs of any person if publication of that information would be ‘unreasonable’
  • other information covered by a determination made by the Australian Information Commissioner if publication of that information would be ‘unreasonable’
  • any information if it is not reasonably practicable to publish the information because of the extent of modifications that would need to be made to delete the information listed in the above dot points.

The information described in the below disclosure log table has been released by the APVMA under the FOI Act and is available for public access.

Any documents uploaded to the APVMA disclosure log may be removed after 12 months of publication.

Information that is not available online may be obtained by emailing?foi@www.hungtuantextile.com. A charge may be imposed to reimburse the APVMA for the cost incurred in copying or reproducing the information or sending it to you. There will be no charge for the time spent by the APVMA in processing the FOI request that led to this information being made available. You will be notified if any charge is payable and you will be required to pay the charge before the information is provided.

There may be documents in the disclosure log that are currently not available in HTML format. If you are unable to read the format provided please contact?foi@www.hungtuantextile.com. The APVMA will try to meet all reasonable requests for an alternate format of the document in a timely manner and at the lowest reasonable cost to you.

Disclosure log table

Note: Documents released as a result of any of the below FOI requests are available from the APVMA upon written request.

APVMA reference number

Date published

Summary of FOI request

Description of documents (released in full or in part)
FOI2020/009 26 May 2020
  1. Amount of MEMC that has been imported into Australia, per year, since 1997
  2. Amount of MEMC that has been manufactured in Australia, per year, since 1997
  3. Amount of MEMC that has been exported from Australia, per year, since 1997
  4. The quantity of MEMC declared by registrants, per year, since 1997, for the calculation of levies charged on MEMC

Access refused to 15 documents relating to items 1–4


Access to part of category 4 refused on the grounds that documents cannot be found or do not exist
FOI2020/008 20 March 2020
  1. The year of registration of product ‘Shirtan Liquid Fungicide’ (No. 49572) with the APVMA
  2. The year that the product was approved by the APVMA to be sold in Australia
  3. Annual quantity of the product sold, as reported to the APVMA since the registration of this product up to 2019??

Items 1 and 2—Documents released in full

?

Item 3—Access to documents refused on the grounds that documents cannot be found or do not exist
FOI2020/002 13 February 2020 List of all cockroach pesticides and insecticides that were recalled, suspended, cancelled or repackaged in 1996 Access to documents refused on the grounds that documents cannot be found or do not exist
FOI2019/003 11 November 2019 Roundup health/toxicology reports. 6 documents released in part
FOI2019/004 10 September 2019
  1. Data from the Agricultural Chemical Usage database
  2. Volume of individual pesticides (or total pesticides) with high spatial resolution ie by state, region, or catchment scale
  3. Sales data with higher spatial resolution ie by state, region, or catchment scale??
 Access to documents refused on the grounds that documents cannot be found or do not exist
LEX 5690 16 August 2019
  1. A copy of the results of the staff survey undertaken in early 2018 and the APVMA’s consequential action plan and updated risk assessment matrix relating to its relocation to Armidale
 1 document released in part
LEX 5691 16 August 2019
  1. A copy of an email trail
 1 document released in part
LEX 5669 15 July 2019

  1. A copy of all assessment reports by the APVMA in relation to methoprene, and

  2. A list of information, eg test and study reports held by the APVMA?

 8 documents released in full
LEX 5635 11 June 2019

Documents in relation to industry-funded travel and/or conferences for APVMA staff in the last five years. Summaries of what has occurred in the past five years may satisfy this request

?

Documents relating to any gifts received from industry to APVMA individual staff, executives, or the department

 1 document released in full and 5 documents released in part
LEX 5592 17 April 2019 The most recent document or progress report to the Chief Executive Officer and/or Deputy Chief Executive Officer of the APVMA on the relocation of the agency that includes information about the impact of the relocation on staff and the organisation’s capacity to perform its functions 1 document released in full.
LEX 5449 5 December 2018

All written correspondence between CropLife Australia and the APVMA in the months:

  • September 2016
  • October 2016
  • November 2016
  • March 2017
  • April 2017
  • March 2018; and
  • August 2018?
including, in the case of emails with attachments, the first two pages of those attachments		 46 documents released in full, 390 documents released in part and access refused to 4 documents
LEX 5457 6?November 2018?
  1. adverse experience reports relating to the NexGard and NexGard Spectra product ranges between August and December 2017; and
  2. communications between the APVMA and the manufacturer concerning any adverse test results and/or any failure of those products to meet all of the statutory criteria for registration

25 documents released in full and 24 documents released in part under category a

?

Access to category b refused on the grounds that documents cannot be found or do not exist
LEX 5391 4 July 2018 Documents containing the identity of a complainant or complainants, and the substance of two complaints made to the APVMA

14 documents released in part

?

Access refused in relation to one document on the grounds that it would disclose lawful methods or procedures for investigating, or dealing with matters arising out, breaches of the law, and would be reasonably likely to prejudice the effectiveness of those methods and procedures
LEX 5285 22 March 2018 Documents concerning progress of APVMA relocation

Six documents released in full


Five documents released in part
LEX 5269 21 February 2018 Documents relating to compliance activity with respect to products containing dimethoate

Three documents released in full


Edited copies of nine document released


Access refused in relation to one document on the grounds that it did not exist
LEX 5267 25 January 2018 Documents relating to the decision to issue Permit 82744 to the Lord Howe Island Board

Four documents released in full


One edited copy of document released
LEX 5104 26 September 2017 Complaint and general compliance information

27 ?documents released in full


Four documents released in part
LEX 5080 29 May 2017 Covering memo and other correspondence relating to the APVMA staff BBQ talking points about the APVMA’s relocation to Armidale

Three documents released in full


Two documents released in part
LEX 5081 18 May 2017 Oakton Consulting digital strategy report and all documents relating to this FOI request Four documents released in full
LEX 5077 16 May 2017 Talking points distributed to APVMA staff on 7 April 2017, described as 'BBQ conversations' over move to Armidale One document released in full
LEX 5012 6 March 2017 Complaints about Track Visual Pty t/a Augustine Approved One document released in full
LEX 4859 1 August 2016 Documents recording or evidencing the accessing by any person for any purpose between 6 August 2012 and the date of the request the composition and impurity profile of a certain active constituent Three documents released in part
LEX 4773 1 July 2016 Documents in relation to the permit application for the importation and use of the active constituent Fluridone, and associated communication relating to Penrith Lakes Scheme Water Bodies Nineteen documents released in part
LEX 4661 17 February 2016 The company name(s), the product (s) concerned and more detail regarding the compliance offences contained in the notices mentioned in your regulatory update number 220 Five documents released in part
LEX 4630 13 January 2016 Copies of e-mails and attachments sent to/from APVMA employees to/from the following e-mail exchanges: @croplife.org.au and @croplife.org from 1 January 2014, narrowing the search to four keywords: Neonicotinoid(s), glyphosate, atrazine, chlorpyrifos Four?documents released in full
LEX 4648 4 January 2016 A list of the products described in the APVMA’s financial report as endocrine system, anabolic steroids and sex hormones One document released in full
LEX 4507 1 September 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible
    reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786
LEX 4443 31 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786
LEX 4431 31 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786
LEX 4423 31 August 2015 A copy of an updated report of the numbers and reactions reported to the Hendra vaccine

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786
LEX 4473 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible?reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786 ?
LEX 4471 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786 ?
LEX 4470 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible?reactions'

One document released in full

?

The document can be accessed at:?www.hungtuantextile.com/node/15786 ?
LEX 4468 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 15
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786 ?
LEX 4442 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and ?9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 Feb 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 15 and 9 February 15
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786 ?
LEX 4465 18 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'
  6. Information regarding my own horse’s case
 Five documents released in full
LEX 4389 10?August 2015 The numbers of reactions to the Equivac Hev vaccine currently being administered under Permits number 14887 and prior Permits 13510 and 14876 reported to the APVMA, and the break-up of those reactions into ‘APVMA Categories’, ie ‘Probable’, ‘Possible’ etc

One document released in full

?

The document can be accessed at: www.hungtuantextile.com/node/15786
LEX 4294 6 August 2015

  1. the total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January and 9 February 2015

  2. the number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015

  3. the number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015

  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘probable reactions’

  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘possible reactions’

 Three documents released in full
LEX 4119 24 November 2014
  1. any submission made by any third party in relation to the APVMA's invitation (pursuant to section 13 of the Agricultural and Veterinary Chemicals Code Act 1994) for submissions in relation to Startect, dated 12 August 2014 (which expired on 12 September) titled 'Public release summary' (Invitation); and
  2. any communication or information received by the APVMA from a third party in relation to the Invitation.
This request is pursuant to the Agricultural and Veterinary Chemicals Code Act 1994 (specifically section 8W(1)) and Freedom of Information Act 1982 		Two submissions released—one in full, one in part

G11233

29 August 2014

Scientific evidence that demonstrates the efficacy of certain APVMA registered pool sanitisers in respect of the 2014 APVMA guidelines

Documents do not exist


Decision

G10968

6 May 2014

Correspondence between the APVMA and Fruit West between 1 January 2012 and 1 January 2014

Emails, letters and notices released in part

G10953

14 April 2014

Adverse experience report prepared by Intervet Australia Pty Ltd (trading as MSD Animal Health) received by the APVMA in 2012 and related correspondence regarding AnguiMonas vaccine (PER12623)

Adverse experience report and correspondence released in part

G10783

3 December 2013

Information concerning trials for Tri-solfen (60099)

Dose determination study on a topical local anaesthetic preparation for use in sheep, field study to evaluate the safety and efficacy of a topical local anaesthetic spray for use in sheep, and safety evaluation on a topical local anaesthetic preparation for use in sheep released in part

G10489

16 October 2013

Unfiltered data (copies of all adverse experience forms marked ‘Lack of effect/poor efficacy’) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers for CPV-2 antigen-containing vaccines administered to dogs of all ages

Adverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part

G10627

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Calefur Sterile Powder for Injection (62682)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10626

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Caleflunix Injection (63989)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10625

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Calesed Injection (63855)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10624

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Caledoxy 100 Tablets (62220)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10631

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 500 Broad Spectrum Antibiotic Tablets (61671)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10630

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 250 Broad Spectrum Antibiotic Tablets (61670)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10629

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 50 Broad Spectrum Antibiotic Tablets (61669)

Notice of Registration and Approval of Label Under the Agvet Codes released in part

G10489

17 July 2013

Unfiltered data (copies of all adverse experience forms) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers, for CPV-2 antigen-containing vaccines administered to dogs of all ages

Adverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part

Contact details for freedom of information enquiries

Phone: +61 2 6770 2388

See also: information about?making a request

Email:?foi@www.hungtuantextile.com

URL: 
http://www.hungtuantextile.com/node/6801
Content last updated: 
22 July 2020
Content last reviewed: 
22 July 2020

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.